Technology-assisted homecare in the UK remains nursing homes' poor relation, despite the potential to reduce the live care needed and solve understaffing issues. HBI speaks to multiple tech experts and asks why it hasn't caught on in the same way.
UK-based digital health company Babylon has hired a trio of new senior management personnel from Amazon, Expedia and Brex. The tech unicorn says the new leadership will work on US-based growth this year.
IBM is on the retreat from its decade long AI in healthcare project: a multi-billion-dollar buy-and-build strategy to gather billions of data points fed into supercomputer Watson. Critics say the business has been unprofitable, overpromised and questioned how fit for purpose it is. HBI gets the inside track.
The quick rise of health apps has meant processes for approval and reimbursement have largely replicated ones for bringing new drugs to market. That is now starting to change, with many of the new reimbursement schemes recognising a need for real-world evidence over randomised clinical trials and new standards being created specifically for apps.
UK teleradiology provider Medica Group has launched a JV with an Australian radiology group to increase reporting capacity for its out-of-hours Nighthawk services and explore new markets including the Middle East, CEO Stuart Quin tells HBI.
A quarter of Swedish regions, home to more than a quarter of all Swedes, have signalled that they will stop paying millions of euros to the country's for-profit telehealth suppliers like Kry.
Many oxygen suppliers have been continuously hostile to innovation that could make delivery more efficient, HBI hears. The pandemic has renewed attention on supply, pricing and patient outcomes leading to some to reassess the approach. HBI speaks to one medical device company that claims to save up to 80% of oxygen for an inpatient.
Vast sums are being invested in so-called “digital health” but there remains surprisingly little medical proof that digital therapeutics, telemonitoring and coaching programmes actually work. And often so-called digital platforms merely knit together analogue processes. For instance, linking millions of diabetes patients to human counsellors and logging their blood sugar and insulin doses online may merely add huge cost without improving outcomes.
Diagnosing and giving therapy can be two very siloed services. Increasingly, innovators are building platforms to understand how the two could come closer together. We speak to one of the world's best-funded AI start-ups, Lunit, about its attempt to integrate diagnostics and therapeutics.
Topics include: Bouncing back from the financial hit of COVID as business becomes brisker Meeting pent-up demand, and the need to relieve pressure on public waiting lists How to persuade payors of the benefits of technology – the advantage of digital pathways Post-COVID consolidation pushes and opportunities; is bigger always beautiful? Panel includes: Tobias Koesters, Partner, […]
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.